These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 36623239)

  • 1. Internet-Based Germline Genetic Testing for Men With Metastatic Prostate Cancer.
    Cheng HH; Sokolova AO; Gulati R; Bowen D; Knerr SA; Klemfuss N; Grivas P; Hsieh A; Lee JK; Schweizer MT; Yezefski T; Zhou A; Yu EY; Nelson PS; Montgomery B
    JCO Precis Oncol; 2023 Jan; 7():e2200104. PubMed ID: 36623239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer.
    Pritchard CC; Mateo J; Walsh MF; De Sarkar N; Abida W; Beltran H; Garofalo A; Gulati R; Carreira S; Eeles R; Elemento O; Rubin MA; Robinson D; Lonigro R; Hussain M; Chinnaiyan A; Vinson J; Filipenko J; Garraway L; Taplin ME; AlDubayan S; Han GC; Beightol M; Morrissey C; Nghiem B; Cheng HH; Montgomery B; Walsh T; Casadei S; Berger M; Zhang L; Zehir A; Vijai J; Scher HI; Sawyers C; Schultz N; Kantoff PW; Solit D; Robson M; Van Allen EM; Offit K; de Bono J; Nelson PS
    N Engl J Med; 2016 Aug; 375(5):443-53. PubMed ID: 27433846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of Germline Variants in Prostate Cancer and Implications for Current Genetic Testing Guidelines.
    Nicolosi P; Ledet E; Yang S; Michalski S; Freschi B; O'Leary E; Esplin ED; Nussbaum RL; Sartor O
    JAMA Oncol; 2019 Apr; 5(4):523-528. PubMed ID: 30730552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germline Sequencing Analysis to Inform Clinical Gene Panel Testing for Aggressive Prostate Cancer.
    Darst BF; Saunders E; Dadaev T; Sheng X; Wan P; Pooler L; Xia LY; Chanock S; Berndt SI; Wang Y; Patel AV; Albanes D; Weinstein SJ; Gnanapragasam V; Huff C; Couch FJ; Wolk A; Giles GG; Nguyen-Dumont T; Milne RL; Pomerantz MM; Schmidt JA; Travis RC; Key TJ; Stopsack KH; Mucci LA; Catalona WJ; Marosy B; Hetrick KN; Doheny KF; MacInnis RJ; Southey MC; Eeles RA; Wiklund F; Conti DV; Kote-Jarai Z; Haiman CA
    JAMA Oncol; 2023 Nov; 9(11):1514-1524. PubMed ID: 37733366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of a universal germline screening program in a community urology practice.
    Mendhiratta N; Hauver H; Hatton W; Ostrusky A; Sathe DS; Gurram S; Rice P; Chalfin H
    Clin Genet; 2024 Sep; 106(3):277-283. PubMed ID: 38711401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Impact of a Rapid Genetic Testing Model for Advanced Prostate Cancer Patients.
    Breen KE; Symecko H; Spielman K; Gebert R; Shah IH; Pundock S; Batson M; Narayan VK; Stadler ZK; Autio KA; Abida W; Danila DC; Scher HI; Morris MJ; Hamilton JG; Robson ME; Domchek SM; Carlo MI
    J Urol; 2023 May; 209(5):918-927. PubMed ID: 36974724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Germline Testing Results of Men With Prostate Cancer: Patient-Level Factors and Implications of NCCN Guideline Expansion.
    Greenberg SE; Hunt TC; Ambrose JP; Lowrance WT; Dechet CB; O'Neil BB; Tward JD
    JCO Precis Oncol; 2021; 5():. PubMed ID: 34250421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germline Genetic Testing in Advanced Prostate Cancer; Practices and Barriers: Survey Results from the Germline Genetics Working Group of the Prostate Cancer Clinical Trials Consortium.
    Paller CJ; Antonarakis ES; Beer TM; Borno HT; Carlo MI; George DJ; Graff JN; Gupta S; Heath EI; Higano CS; McKay RR; Morgans AK; Patnaik A; Petrylak DP; Rettig MB; Ryan CJ; Taplin ME; Whang YE; Vinson J; Cheng HH; Giri VN;
    Clin Genitourin Cancer; 2019 Aug; 17(4):275-282.e1. PubMed ID: 31171481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germline DNA Damage Response Gene Mutations in Localized Prostate Cancer.
    Januskevicius T; Vaicekauskaite I; Sabaliauskaite R; Matulevicius A; Vezelis A; Ulys A; Jarmalaite S; Jankevicius F
    Medicina (Kaunas); 2023 Dec; 60(1):. PubMed ID: 38256334
    [No Abstract]   [Full Text] [Related]  

  • 10. Satisfaction With Clinician-Led Germline Genetic Counseling in Patients With Prostate Cancer.
    Abusamra SM; Solorzano MA; Luke M; Quarles J; Jacobs MF; Das S; Kasputis A; Okoth LA; Patel M; Seymore M; Caram MEV; Dunn RL; Merajver SD; Stoffel EM; Reichert ZR; Morgan TM
    J Urol; 2022 Nov; 208(5):1007-1017. PubMed ID: 35930793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germline Mutations and Ancestry in Prostate Cancer.
    Bataba E; Babcock K; Isensee KA; Eldhose B; Kohaar I; Chesnut GT; Dobi A
    Curr Oncol Rep; 2024 Feb; 26(2):175-180. PubMed ID: 38265515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pilot Trial of Streamlined Genetic Education and Traceback Genetic Testing in Prostate Cancer Survivors.
    Schwartz MD; Peshkin BN; Isaacs C; Grisham C; Holmes NJ; Sorgen LJ; Collins S; Dawson N; McGuire C; Okobi T; Newell K; Kolla KA; Weinstein V
    J Natl Compr Canc Netw; 2023 Dec; 21(12):1261-1268.e14. PubMed ID: 38081141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TARGET: A Randomized, Noninferiority Trial of a Pretest, Patient-Driven Genetic Education Webtool Versus Genetic Counseling for Prostate Cancer Germline Testing.
    Loeb S; Keith SW; Cheng HH; Leader AE; Gross L; Sanchez Nolasco T; Byrne N; Hartman R; Brown LH; Pieczonka CM; Gomella LG; Kelly WK; Lallas CD; Handley N; Mille PJ; Mark JR; Brown GA; Chopra S; McClellan A; Wise DR; Hollifield L; Giri VN
    JCO Precis Oncol; 2024 Mar; 8():e2300552. PubMed ID: 38452310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of an Embedded In-Clinic Genetic Testing Station to Optimize Germline Testing for Patients with Pancreatic Adenocarcinoma.
    Walker EJ; Goldberg D; Gordon KM; Pedley C; Carnevale J; Cinar P; Collisson EA; Tempero MA; Ko AH; Blanco AM; Dhawan M
    Oncologist; 2021 Nov; 26(11):e1982-e1991. PubMed ID: 34506673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practical Considerations and Challenges for Germline Genetic Testing in Patients With Prostate Cancer: Recommendations From the Germline Genetics Working Group of the PCCTC.
    Szymaniak BM; Facchini LA; Giri VN; Antonarakis ES; Beer TM; Carlo MI; Danila DC; Dhawan M; George D; Graff JN; Gupta S; Heath E; Higano CS; Liu G; Molina AM; Paller CJ; Patnaik A; Petrylak DP; Reichert Z; Rettig MB; Ryan CJ; Taplin ME; Vinson J; Whang YE; Morgans AK; Cheng HH; McKay RR
    JCO Oncol Pract; 2020 Dec; 16(12):811-819. PubMed ID: 32986533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a Novel Protocol for Germline Testing in Pancreatic Cancer.
    McDonald HG; Kennedy A; Solomon AL; Williams CM; Reagan AM; Cassim E; Harper M; Burke E; Armstrong T; Gosky M; Cavnar M; Pandalai PK; Barry-Hundeyin M; Patel R; Nutalapati S; Moss J; Hull PC; Kolesar J; Pickarski JC; Kim J
    Ann Surg Oncol; 2024 Aug; ():. PubMed ID: 39133448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discussing the predictive, prognostic, and therapeutic value of germline DNA-repair gene mutations in metastatic prostate cancer patients.
    Hauke RJ; Sissung TM; Figg WD
    Cancer Biol Ther; 2017 Aug; 18(8):545-546. PubMed ID: 28678600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of DNA-Repair Gene mutations in Mexican men with prostate cancer.
    Cruz Garcia Villa P; Izunza Laisequilla A; Puga Ortega E; Alaez Verson C
    Actas Urol Esp (Engl Ed); 2024 May; ():. PubMed ID: 38735436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of clinical selection-based genetic testing with phenotype-agnostic extensive germline sequencing to diagnose genetic predisposition in children with cancer: a prospective diagnostic study.
    Bakhuizen JJ; van Dijk F; Koudijs MJ; Bladergroen RS; Bon SBB; Hopman SMJ; Kester LA; Kranendonk MEG; Loeffen JLC; Smetsers SE; Sonneveld E; Tachdjian M; de Vos-Kerkhof E; Goudie C; Merks JHM; Kuiper RP; Jongmans MCJ
    Lancet Child Adolesc Health; 2024 Oct; 8(10):751-761. PubMed ID: 39159644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delivering Genetic Testing for Patients with Prostate Cancer: Moving Beyond Provider Knowledge as a Barrier to Care.
    Gunn CM; Li EX; Gignac GA; Pankowska M; Loo S; Zayhowski K; Wang C
    Cancer Control; 2023; 30():10732748221143884. PubMed ID: 36946278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.